Drug Information Related to Patanase Nasal Spray
01. invivodata's DiaryPRO Captures Primary Efficacy Data for PATANASE Nasa...
Alcon Receives FDA Approval to Market PATANASE in U.S.
PITTSBURGH -- invivodata inc., the industry leader in electronic
patient reported outcomes (ePRO) solutions and services for global
clinical research, today announced that its eDiary solution,
DiaryPRO([R]...
02. Alcon's PATANASE® Nasal Spray Approved by FDA for Treatment of Nasal ...
HUENENBERG, Switzerland -- Alcon, Inc. (NYSE: ACL) announced today that the U.S. Food and Drug Administration (FDA) has approved PATANASE([R]) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of ...
03. invivodata's DiaryPRO Captures Primary Efficacy Data for PATANASE Nasa...
Alcon Receives FDA Approval to Market PATANASE in U.S.
...